6951 - 6975 of 8785 Results
Title
Year
-
OPENTitle: The longevity gene Klotho and its cerebrospinal fluid protein profiles as a modifier for Parkinson´s diseaseJournal Name: European Journal of NeurologyPublisher: WileyVol: 28Issue #: 5Start Page: 1557End Page: 1565Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1111/ene.14733Best OA location URL: https://doi.org/10.1111/ene.14733Citation Count: 23
-
OPENTitle: Neuropsychological Test Performances and Depression in Early-Stage De Novo Parkinson’s DiseaseJournal Name: Archives of Clinical NeuropsychologyPublisher: Oxford University Press (OUP)Vol: 36Issue #: 1Start Page: 112End Page: 116Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/arclin/acz067Best OA location URL: https://academic.oup.com/acn/article-pdf/36/1/112/35858436/acz067.pdfCitation Count: 5
-
OPENTitle: A highly efficient, scalable pipeline for fixed feature extraction from large-scale high-content imaging screensJournal Name: iSciencePublisher: Elsevier BVVol: 27Issue #: 12Start Page: 111434End Page: 111434Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1016/j.isci.2024.111434Best OA location URL: https://doi.org/10.1016/j.isci.2024.111434Citation Count: 0
-
OPENTitle: Exploring the layers of fatigue in Parkinson’s Disease: A comprehensive analysis of its prevalence and contributing factorsJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 11Issue #:Start Page: 100288End Page: 100288Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.prdoa.2024.100288Best OA location URL: https://doi.org/10.1016/j.prdoa.2024.100288Citation Count: 1
-
RESTRICTEDTitle: A cognitive fMRI study in non-manifesting LRRK2 and GBA carriersJournal Name: Brain Structure and FunctionPublisher: Springer Science and Business Media LLCVol: 222Issue #: 3Start Page: 1207End Page: 1218Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00429-016-1271-4Citation Count: 21
-
OPENTitle: Transportation innovation to aid Parkinson disease trial recruitmentJournal Name: Contemporary Clinical Trials CommunicationsPublisher: Elsevier BVVol: 16Issue #:Start Page: 100449End Page: 100449Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.conctc.2019.100449Best OA location URL: https://doi.org/10.1016/j.conctc.2019.100449Citation Count: 9
-
OPENTitle: Analysis of a precision medicine approach to treating Parkinson's disease: Analysis of the DATATOP studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 94Issue #:Start Page: 15End Page: 21Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.11.027Best OA location URL: https://doi.org/10.1016/j.parkreldis.2021.11.027Citation Count: 7
- Elevated cholesterol is a common phenotype for dominant and recessive ATAD3-associated disorders2024OPENTitle: Elevated cholesterol is a common phenotype for dominant and recessive ATAD3-associated disordersJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 148Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awae402Best OA location URL: https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awae402/61091141/awae402.pdfCitation Count: 1
-
RESTRICTEDTitle: At last, a randomised controlled trial of apomorphine infusionJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 17Issue #: 9Start Page: 732End Page: 733Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(18)30284-9Citation Count: 3
-
OPENTitle: Longitudinal qualitative assessment of meaningful symptoms and relevance of WATCH-PD digital measures for people with early Parkinson’sJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 272Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-024-12789-0Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00415-024-12789-0.pdfCitation Count: 5
-
OPENTitle: Toward a biomarker panel measured in CNS-originating extracellular vesicles for improved differential diagnosis of Parkinson’s disease and multiple system atrophyJournal Name: Translational NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40035-023-00346-0Best OA location URL: https://translationalneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s40035-023-00346-0Citation Count: 26
-
OPENTitle: First-in-Human PET Imaging of [18F]SDM-4MP3: A Cautionary TaleJournal Name: Molecular ImagingPublisher: SAGE PublicationsVol: 2023Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2023/8826977Best OA location URL: https://downloads.hindawi.com/journals/moi/2023/8826977.pdfCitation Count: 2
-
OPENTitle: Biallelic NDUFA13 variants lead to a neurodevelopmental phenotype with gradual neurological impairmentJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcae453Best OA location URL: https://academic.oup.com/braincomms/advance-article-pdf/doi/10.1093/braincomms/fcae453/61218229/fcae453.pdfCitation Count: 2
-
OPENTitle: Multimodal assessment of nigrosomal degeneration in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 80Issue #:Start Page: 102End Page: 107Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.09.021Best OA location URL: https://arxiv.org/pdf/2009.01378Citation Count: 17
-
OPENTitle: Paroxysmal abdominalgia as a non-motor wearing off phenomenon in Parkinson’s disease. A case series and literature reviewJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 13Issue #:Start Page: 100368End Page: 100368Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.prdoa.2025.100368Best OA location URL: https://doi.org/10.1016/j.prdoa.2025.100368Citation Count: 0
-
RESTRICTEDTitle: White matter microstructural organizations in patients with severe treatment-resistant schizophrenia: A diffusion tensor imaging studyJournal Name: Progress in Neuro-Psychopharmacology and Biological PsychiatryPublisher: Elsevier BVVol: 100Issue #:Start Page: 109871End Page: 109871Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.pnpbp.2020.109871Citation Count: 29
-
OPENTitle: α‐Synuclein Pathology in PRKN‐Linked Parkinson's Disease: New Insights from a Blood‐Based Seed Amplification AssayJournal Name: Annals of NeurologyPublisher: WileyVol: 95Issue #: 6Start Page: 1173End Page: 1177Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/ana.26917Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.26917Citation Count: 18
-
RESTRICTEDTitle: Cerebrospinal fluid hemoglobin levels as markers of blood contamination: relevance for α-synuclein measurementJournal Name: Clinical Chemistry and Laboratory Medicine (CCLM)Publisher: Walter de Gruyter GmbHVol: 59Issue #: 10Start Page: 1653End Page: 1661Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1515/cclm-2020-1521Citation Count: 6
-
OPENTitle: Patient-centred management of Parkinson's disease – Authors' replyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 11Start Page: 889End Page: 890Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30360-4Best OA location URL: http://www.thelancet.com/article/S1474442220303604/pdfCitation Count: 0
- Falls in people with Parkinson’s disease: A prospective comparison of community and home-based falls2017RESTRICTEDTitle: Falls in people with Parkinson’s disease: A prospective comparison of community and home-based fallsJournal Name: Gait & PosturePublisher: Elsevier BVVol: 55Issue #:Start Page: 62End Page: 67Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.gaitpost.2017.04.005Citation Count: 41
-
RESTRICTEDTitle: Exploring the neuroprotective potential of immunosuppressants in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 132Issue #:Start Page: 107294End Page: 107294Publication Date:Open Access(OA) Status: RESTRICTEDLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107294Best OA location URL: https://doi.org/10.1016/j.parkreldis.2025.107294Citation Count: 0
-
OPENTitle: Proximity extension assay testing reveals novel diagnostic biomarkers of atypical parkinsonian syndromesJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 90Issue #: 7Start Page: 768End Page: 773Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1136/jnnp-2018-320151Best OA location URL: https://jnnp.bmj.com/content/jnnp/90/7/768.full.pdfCitation Count: 50
-
OPENTitle: Cognitive Performance Patterns in Healthy Individuals with Substantia Nigra Hyperechogenicity and Early Parkinson’s DiseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 8Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2016.00271Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2016.00271/pdfCitation Count: 7
-
OPENTitle: Brain‐Targeted Liposomes Loaded with Monoclonal Antibodies Reduce Alpha‐Synuclein Aggregation and Improve Behavioral Symptoms in Parkinson's DiseaseJournal Name: Advanced MaterialsPublisher: WileyVol: 35Issue #: 51Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/adma.202304654Best OA location URL: https://doi.org/10.1002/adma.202304654Citation Count: 58
-
RESTRICTEDTitle: Increased Brain Exposure of an Alpha-Synuclein Fibrillization Modulator by Utilization of an Activated Ester Prodrug StrategyJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 9Issue #: 11Start Page: 2542End Page: 2547Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.8b00236Citation Count: 12